Stay up-to-date with all of the life science events taking place in Vancouver with the Science in the City events calendar! From academia to industry and biotech to pharma, our events calendar is your complete source for life science conferences, symposiums, networking, and workshops in Vancouver. We even cover science pub nights and science fundraisers!
If you’re interested in promoting your life science event on the Science in the City events calendar, please use our event submission form.
- This event has passed.
International Infection, Immunity and Inflammation Conference (I4C)
May 14, 2019 - 15, 2019
It is with great honour and privilege to welcome you to the first annual International Infection, Immunity and Inflammation Conference (I4C) at the University of British Columbia in Vancouver, Canada. We are pleased to bring together a diverse group of researchers, academics, and industry leaders to share with you the latest in the fields of Pseudomonas, Systems Biology, Peptides, New Therapeutic Discoveries and Innate Immunity.
We hope you will take this excellent opportunity to network, learn, and exchange ideas about the field with colleagues in the field from all over the world.
The I4C is being held to celebrate the 70th birthday and 40-year research career of Bob Hancock at UBC. During his time at UBC he has made numerous break-throughs in the field of cationic host defence (antimicrobial) peptides and finding alternate treatments to antibiotic resistance.
Hancock is “considered a world leader in his field” and over his career he has published more than 720 papers and reviews, has 65 patents awarded, and is an ISI highly cited author in Microbiology with more than 72,000 citations and an h-index of 153. He has won several awards and is an Officer of the Order of Canada. He is a co-founder of Migenix, Inimex Pharmaceuticals, ABT Innovations, Sepset Biotherapeutics, and the Centre for Drug Research and Development.
Currently Hancock and his lab’s research interests include small cationic peptides as novel antimicrobials, broad-spectrum anti-biofilm agents, and modulators of innate immunity, the development of novel treatments for antibiotic resistant infections and inflammation, the systems biology of innate immunity, inflammatory diseases and Pseudomonas aeruginosa, and antibiotic uptake and resistance.